Partner Headlines - ILMN

  1. Baron Funds Comments on Illumina Inc.

    GuruFocus
  2. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  3. Stocks Open Down, Reverse Higher; Prestige, Nike, Fastenal Soar

    IBD
  4. Benzinga's Top Downgrades

    Benzinga
  5. Stock Indexes Trade Mixed, But Medicals Fall; Illumina Hits Low

    IBD
  6. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits ...

    IBD
  7. Illumina Names Dr. Frances Arnold to Board of Directors

    Benzinga
  8. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD
  9. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD
  10. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD
  11. Illumina Forms GRAIL to Enable Early Cancer Detection via Blood-Based ...

    Benzinga
  12. Apple Supplier Avago A Top Pick; BlackBerry PT Hiked

    IBD
  13. Should You Wait to Bet on Agilent Technologies?

    GuruFocus
  14. Steve Mandel Acquires Stakes in Amazon.com and Constellation ...

    GuruFocus
  15. Desktop Genetics Receives Strategic Investment from Illumina

    Benzinga
  16. John Griffin Buys Autodesk, Apple, Sells AIG, Fitbit

    GuruFocus
  17. Julian Robertson Keeps Buying Citigroup, Netflix, Facebook

    GuruFocus
  18. Frank Sands Invests in Stake in Amazon.com

    GuruFocus
  19. Facebook, Apple, Gilead Honchos Lead Insider Deals

    IBD
  20. Benzinga's Volume Movers

    Benzinga
  21. Morning Market Gainers

    Benzinga
  22. Benzinga's Top #PreMarket Gainers

    Benzinga
  23. Don't Allow A Healthy Winner To Turn Into A Loser

    IBD
  24. Baron Funds Comments on Illumina Inc.

    GuruFocus
  25. Stocks Slip, Retake Slim Gains; Monster, Bank Of The Ozarks Rise

    IBD
  26. Benzinga's Top Downgrades

    Benzinga
  27. Nasdaq, S&P 500 End Win Streaks; Autobytel Gains

    IBD
  28. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  29. Stocks Wrestle In Mixed Action; DuPont Surges, Illumina Dives

    IBD
  30. Morning Market Losers

    Benzinga
  31. Benzinga's Top Downgrades

    Benzinga
  32. Stock Futures Down, Off Lows On News From DuPont, Pepsi, Illumina

    IBD
  33. Illumina Downgraded; Apple Supplier Skyworks PT Cut

    IBD
  34. Benzinga's Top #PreMarket Losers

    Benzinga
  35. Illumina Plunges On Outlook

    IBD
  36. Stock Leadership Has Dumped Medical, Turned Diverse

    IBD
  37. Illumina Stock Dives On Latest Sales Warning

    IBD
  38. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD
  39. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD
  40. Stocks End Narrowly Mixed Ahead Of Job Report

    IBD
  41. Illumina Tumbles On Downgrade, New Competition

    IBD
  42. Apple Supplier Skyworks Is A Buy; Celgene Upgraded

    IBD
  43. Stocks Move Lower; Slow Sales Take Bite Out Of Dunkin' Brands

    IBD
  44. Stocks Give Up Early Gains As Apple, Illumina, Sucampo Slide

    IBD
  45. Morning Market Losers

    Benzinga
  46. Benzinga's Top Downgrades

    Benzinga
  47. Apple Supplier Skyworks Is A Buy; Celgene Upgraded

    IBD
  48. Benzinga's Top #PreMarket Losers

    Benzinga
  49. Netflix, Google CEOs Top This Week's Insider Sales

    IBD
  50. BioMed Realty Trust REIT Looks For A Buyer

    IBD
  51. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  52. Frank Sands Shows Bold Side in Second-Quarter Trades

    GuruFocus
  53. Perigon Wealth Management's Largest Buys in Second Quarter

    GuruFocus
  54. Benzinga's Top Initiations

    Benzinga
  55. Burning Rock, Illumina Announce Collaboration on Molecular Diagnostics ...

    Benzinga
  56. Baron Funds Comments on Illumina Inc.

    GuruFocus
  57. Baron Funds Comments on Illumina Inc.

    GuruFocus
  58. Illumina, Warburg Pincus, Sutter Hill Ventures Form Helix With ...

    Benzinga
  59. Good Stocks Differ, So Know What You're Looking At

    IBD
  60. Big Cap Leaders Sail Past Earnings Season

    IBD
  61. 4 IBD 50 Stocks Poised To Bounce Back With Market

    IBD
  62. Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market

    IBD
  63. Bruised Apple Batters Stocks

    IBD
  64. Illumina Breaches Key Level On Q2 Sales Miss

    IBD
  65. Comeback Efforts Lose Steam; Lithia Revs Higher

    IBD
  66. Morning Market Losers

    Benzinga
  67. Stock Futures Down, Action Mixed; Apple, Vasco, Illumina Tumble

    IBD
  68. Benzinga's Top #PreMarket Losers

    Benzinga
  69. Illumina Disappoints On Sales

    IBD
  70. GoPro, Fitbit Surge As Indexes Dip; Apple Down Late

    IBD
  71. Illumina Stock Dives As Q2 Earnings Beat, Sales Miss

    IBD
  72. Stock Futures Mixed, IBM Weighs; Infosys, Tesla, Apple In Motion

    IBD
  73. Earnings Loom For Handful Of Top Big Cap 20 Stocks

    IBD
  74. Move Aside Apple: 8 IBD 50 Stocks With Earnings Due

    IBD
  75. Newfound Market Strength Could Benefit These IBD 50 Names

    IBD
  76. Google Rally Masks Weakness; Domino's Falls, SolarWinds Crushed

    IBD
  77. As Biotech Beats, 6 Top ETF Picks For Rest Of 2015

    IBD
  78. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD
  79. Top Mutual Funds Add Abiomed, Tech Stocks And Monster

    IBD
  80. Big Cap 20: Does Edwards Lifesciences Have More Left?

    IBD
  81. 5 IBD 50 Stocks Hold Tight After Monday's Plunge

    IBD
  82. Big Cap Leaders Slide As Much As 4.7%

    IBD
  83. How Will Internet Of Things Change Health Care?

    IBD
  84. Internet ready to go to health

    IBD
  85. Internet Of Things Coming To U.S. Health Care

    IBD
  86. For The Record

    IBD
  87. Illumina, A Gene Research Leader, In Buy Range

    IBD
  88. Stock Futures Shifting Lower; Illumina, Lennar, Netflix Climb

    IBD
  89. Gilead Leads 4 Top Stocks In Or Near Top Of Buy Areas

    IBD
  90. IBD 50 Stocks Illumina, Avago Tech In Buy Range

    IBD
  91. Illumina Leads In Medicine's Next Frontier: Genetics

    IBD
  92. Top Stock INC Research Up 6 Weeks In Row, In Buy Zone

    IBD
  93. San Diego-Based Illumina Inc's Stock Is Overvalued

    GuruFocus
  94. Winning Streaks Could Send These Medicals Even Higher

    IBD
  95. Sharp Rally Sends These Spotlight Stocks To New Highs

    IBD
  96. 3 Fast-Growing Health Care Outsourcers Holding Up

    IBD
  97. Stocks Rebound To Mixed Finish; Illumina Hits New High

    IBD
  98. Nasdaq Flat, S&P 500 Up 0.2% As Indexes Keep Rebounding

    IBD
  99. Illumina HiSeq faces new rival

    IBD
  100. Skyworks, Nike Among Big Cap 20 Stocks Pulling Back

    IBD
Trading Center